Related Experiment Videos
Apoptosis in HIV-1 infection
1Communicable Diseases Directorate, E Floor, Royal Hallamshire Hospital, Glossop Road, Sheffield, UK.
Summary
Apoptosis, programmed cell death, significantly contributes to CD4 T-lymphocyte decline in HIV infection. Antiretroviral therapy can alter these apoptosis pathways, impacting disease progression.
Area of Science:
- Immunology
- Cell Biology
- Virology
Background:
- Apoptosis is crucial for immune system homeostasis.
- Dysregulation of apoptosis contributes to human diseases like HIV.
- CD4 T-lymphocyte depletion in HIV is multifactorial, with apoptosis playing a significant role.
Purpose of the Study:
- To investigate the role of apoptosis in HIV-associated CD4 T-lymphocyte loss.
- To explore the specific pathways of apoptosis induction in HIV infection.
- To assess the impact of antiretroviral therapy on apoptosis in HIV.
Main Methods:
- Analysis of apoptosis levels in HIV-infected and uninfected cells.
- Investigation of death receptor and mitochondrial apoptosis pathways.
- Correlation of apoptosis induction with specific HIV proteins.
- Evaluation of changes in apoptosis following antiretroviral therapy.
Main Results:
- Apoptosis alterations are evident in both infected and bystander cells during HIV infection.
- Both death receptor and mitochondrial pathways are implicated in HIV-induced apoptosis.
- Specific HIV proteins are linked to apoptosis induction.
- Antiretroviral therapy demonstrably alters apoptosis pathways.
Conclusions:
- Apoptosis is a key mechanism driving CD4 T-lymphocyte decline in HIV.
- Understanding HIV-induced apoptosis pathways is critical for therapeutic strategies.
- Antiretroviral therapy modulates HIV-related apoptosis, offering potential for immune restoration.